Get started
Author

D. J. McCormick

Observed names: D. McCormick, DAN McCORMICK, Dan McCormick
Institution: Mayo Clinic
Observed institution: Mayo Clinic
OpenAlex ID: A5004158882
FDA Advisory Panel on the Safety and Efficacy of Drug‐Eluting Stents: Summary of Findings and Recommendations
2007 · JEFFREY J. POPMA, BONNIE WEINER, et al. · Journal of Interventional Cardiology · 27
Characterization of a purified chromatin acceptor protein (receptor binding factor 1) for the avian oviduct progesterone receptor
1991 · M. Schuchard, J. J. Rejman, et al. · Biochemistry · 19
Npa7, a First in Class Dual Receptor Activator With Cardio-renoprotective Properties in Vivo
2017 · Laura Meems, Ingrid Andersen, et al. · Journal of the American College of Cardiology · 1
PDF
Erratum: Chimeric rat/human neurotensin receptors localize a region of the receptor sensitive to binding of a novel, species-specific picomolar affinity peptide (Journal of Biological Chemistry (1996) 271 (15054-15059))
1996 · B. Cusak, Karen Groshan, et al. · Journal of Biological Chemistry · 1
Proteomic analysis of patients with mantle cell lymphoma identifies Hsp90, and other proteins as potential target(s) for drug therapy
2004 · I. M. Ghobrial, D. J. McCormick, et al. · Journal of Clinical Oncology
166. Development of a neurotensin agonist crossing the blood brain barrier
1998 · B. Cusack, B.M. Tyler, et al. · Biological Psychiatry
Neurotensin receptors in brain as targets for new neuropsychiatric drugs
1997 · E. Richelson, B. Cusack, et al. · Biological Psychiatry
Works count: 7
Citation count: 48
H-index: 2
I10-index: 2
Year
Topic
Type